Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 296 | 2024 | 10896 | 14.900 |
Why?
|
Stroke Volume | 200 | 2024 | 5002 | 8.690 |
Why?
|
Tetrazoles | 64 | 2024 | 834 | 6.520 |
Why?
|
Angiotensin Receptor Antagonists | 72 | 2024 | 923 | 6.470 |
Why?
|
Spironolactone | 35 | 2024 | 382 | 5.760 |
Why?
|
Biphenyl Compounds | 67 | 2024 | 913 | 4.950 |
Why?
|
Enalapril | 37 | 2024 | 327 | 4.920 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 49 | 2024 | 1516 | 3.640 |
Why?
|
Ventricular Function, Left | 63 | 2024 | 3660 | 2.770 |
Why?
|
Hyperkalemia | 12 | 2019 | 218 | 2.750 |
Why?
|
Glucosides | 26 | 2024 | 451 | 2.410 |
Why?
|
Drug Combinations | 59 | 2024 | 1958 | 2.350 |
Why?
|
Neprilysin | 19 | 2023 | 439 | 2.310 |
Why?
|
Benzhydryl Compounds | 33 | 2024 | 844 | 2.310 |
Why?
|
Ventricular Dysfunction, Left | 28 | 2024 | 2074 | 2.300 |
Why?
|
Hospitalization | 73 | 2024 | 10259 | 2.300 |
Why?
|
Diuretics | 18 | 2024 | 591 | 2.240 |
Why?
|
Natriuretic Peptide, Brain | 31 | 2024 | 1572 | 2.190 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 7 | 2023 | 135 | 1.950 |
Why?
|
Pulmonary Artery | 12 | 2022 | 1911 | 1.610 |
Why?
|
Antihypertensive Agents | 18 | 2024 | 2047 | 1.470 |
Why?
|
Peptide Fragments | 26 | 2024 | 5096 | 1.460 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 7 | 2023 | 236 | 1.340 |
Why?
|
Anemia | 12 | 2023 | 1502 | 1.290 |
Why?
|
Diabetes Mellitus, Type 2 | 33 | 2024 | 11729 | 1.160 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 14 | 2020 | 452 | 1.150 |
Why?
|
Heart-Assist Devices | 5 | 2023 | 1195 | 1.100 |
Why?
|
Humans | 356 | 2024 | 743811 | 1.090 |
Why?
|
Cardiac Resynchronization Therapy | 5 | 2020 | 531 | 1.020 |
Why?
|
Fumarates | 12 | 2020 | 132 | 1.020 |
Why?
|
Aged | 163 | 2024 | 163178 | 1.010 |
Why?
|
Potassium | 7 | 2022 | 1336 | 0.980 |
Why?
|
Double-Blind Method | 52 | 2024 | 12020 | 0.980 |
Why?
|
Angiotensinogen | 2 | 2024 | 163 | 0.930 |
Why?
|
Hypertension | 15 | 2024 | 8480 | 0.930 |
Why?
|
Hypokalemia | 5 | 2019 | 153 | 0.900 |
Why?
|
Amides | 12 | 2020 | 459 | 0.870 |
Why?
|
Prognosis | 64 | 2024 | 29052 | 0.860 |
Why?
|
Renal Insufficiency, Chronic | 12 | 2023 | 2200 | 0.860 |
Why?
|
Patient Readmission | 7 | 2018 | 3117 | 0.840 |
Why?
|
Natriuretic Peptides | 5 | 2023 | 150 | 0.830 |
Why?
|
Defibrillators, Implantable | 8 | 2021 | 1439 | 0.820 |
Why?
|
Disease Management | 7 | 2019 | 2459 | 0.820 |
Why?
|
Cardiac Output, Low | 2 | 2017 | 195 | 0.820 |
Why?
|
Glomerular Filtration Rate | 11 | 2024 | 2167 | 0.810 |
Why?
|
Male | 191 | 2024 | 349776 | 0.800 |
Why?
|
Cardiomyopathies | 9 | 2023 | 1911 | 0.790 |
Why?
|
Middle Aged | 145 | 2024 | 213241 | 0.780 |
Why?
|
Kidney Diseases | 7 | 2023 | 2146 | 0.760 |
Why?
|
Guideline Adherence | 3 | 2021 | 2265 | 0.750 |
Why?
|
Angiotensins | 3 | 2023 | 151 | 0.750 |
Why?
|
Heart Failure, Diastolic | 5 | 2023 | 69 | 0.740 |
Why?
|
Atrial Fibrillation | 14 | 2023 | 5033 | 0.740 |
Why?
|
Cardiovascular Diseases | 30 | 2022 | 15142 | 0.740 |
Why?
|
Female | 190 | 2024 | 380020 | 0.730 |
Why?
|
Temporal Arteries | 2 | 2017 | 128 | 0.710 |
Why?
|
Death, Sudden, Cardiac | 12 | 2021 | 1542 | 0.700 |
Why?
|
Troponin T | 6 | 2023 | 754 | 0.700 |
Why?
|
Cause of Death | 15 | 2021 | 3580 | 0.690 |
Why?
|
Cardiac Resynchronization Therapy Devices | 3 | 2020 | 124 | 0.680 |
Why?
|
Palliative Care | 5 | 2022 | 3490 | 0.680 |
Why?
|
Edema, Cardiac | 1 | 2018 | 18 | 0.660 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.640 |
Why?
|
Monitoring, Ambulatory | 3 | 2022 | 358 | 0.640 |
Why?
|
Benzimidazoles | 8 | 2020 | 850 | 0.640 |
Why?
|
Kidney | 11 | 2023 | 7185 | 0.620 |
Why?
|
Exanthema | 1 | 2022 | 501 | 0.620 |
Why?
|
Treatment Outcome | 71 | 2023 | 63042 | 0.610 |
Why?
|
Renin | 6 | 2016 | 642 | 0.610 |
Why?
|
Furosemide | 7 | 2023 | 167 | 0.600 |
Why?
|
Hematinics | 7 | 2017 | 280 | 0.600 |
Why?
|
Cachexia | 1 | 2019 | 205 | 0.590 |
Why?
|
Heart Failure, Systolic | 4 | 2023 | 126 | 0.590 |
Why?
|
Shock, Cardiogenic | 1 | 2022 | 688 | 0.590 |
Why?
|
Hydrazones | 1 | 2017 | 102 | 0.580 |
Why?
|
Giant Cell Arteritis | 2 | 2017 | 292 | 0.570 |
Why?
|
Social Work | 1 | 2018 | 162 | 0.570 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2020 | 264 | 0.570 |
Why?
|
Nutrition Assessment | 2 | 2019 | 723 | 0.560 |
Why?
|
Aged, 80 and over | 47 | 2022 | 57744 | 0.560 |
Why?
|
Hemodynamics | 12 | 2024 | 4197 | 0.550 |
Why?
|
Prospective Studies | 46 | 2023 | 53250 | 0.520 |
Why?
|
Ambulatory Care | 6 | 2019 | 2707 | 0.520 |
Why?
|
Heart Valve Diseases | 3 | 2023 | 1073 | 0.510 |
Why?
|
Quality of Life | 24 | 2023 | 12788 | 0.500 |
Why?
|
Home Care Services | 2 | 2012 | 608 | 0.500 |
Why?
|
Renin-Angiotensin System | 4 | 2020 | 758 | 0.490 |
Why?
|
Hyperemia | 1 | 2015 | 225 | 0.490 |
Why?
|
Patient Dropouts | 2 | 2016 | 420 | 0.490 |
Why?
|
Troponin I | 1 | 2018 | 619 | 0.480 |
Why?
|
Aorta | 2 | 2013 | 2062 | 0.460 |
Why?
|
Advance Care Planning | 2 | 2020 | 662 | 0.460 |
Why?
|
Patient Care Planning | 2 | 2019 | 915 | 0.460 |
Why?
|
Risk Assessment | 22 | 2023 | 23327 | 0.460 |
Why?
|
Hypotension | 5 | 2024 | 884 | 0.460 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2015 | 585 | 0.440 |
Why?
|
Diabetic Nephropathies | 4 | 2015 | 984 | 0.430 |
Why?
|
Blood Pressure | 14 | 2024 | 8551 | 0.430 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 941 | 0.430 |
Why?
|
Coronary Stenosis | 2 | 2017 | 833 | 0.420 |
Why?
|
Vascular Resistance | 2 | 2012 | 936 | 0.420 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2021 | 1240 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3134 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.410 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 7270 | 0.410 |
Why?
|
Randomized Controlled Trials as Topic | 24 | 2023 | 9944 | 0.400 |
Why?
|
Sodium | 5 | 2022 | 1622 | 0.400 |
Why?
|
Cardiovascular Agents | 6 | 2019 | 850 | 0.400 |
Why?
|
Survival Rate | 24 | 2021 | 12786 | 0.390 |
Why?
|
Diastole | 4 | 2014 | 791 | 0.390 |
Why?
|
Follow-Up Studies | 32 | 2021 | 39001 | 0.390 |
Why?
|
Patient Care Team | 2 | 2020 | 2528 | 0.390 |
Why?
|
Triage | 3 | 2018 | 977 | 0.380 |
Why?
|
Telemedicine | 3 | 2020 | 2874 | 0.380 |
Why?
|
Ventricular Remodeling | 3 | 2013 | 1225 | 0.380 |
Why?
|
Albuminuria | 5 | 2018 | 681 | 0.380 |
Why?
|
Prediabetic State | 3 | 2022 | 499 | 0.380 |
Why?
|
Surgical Procedures, Operative | 1 | 2022 | 1877 | 0.380 |
Why?
|
Pheochromocytoma | 2 | 2009 | 337 | 0.370 |
Why?
|
Infusions, Intravenous | 5 | 2019 | 2274 | 0.370 |
Why?
|
Coronary Occlusion | 1 | 2013 | 304 | 0.370 |
Why?
|
Hemoglobins | 3 | 2013 | 1531 | 0.360 |
Why?
|
Diabetes Mellitus | 9 | 2023 | 5752 | 0.360 |
Why?
|
Drug-Eluting Stents | 3 | 2017 | 753 | 0.360 |
Why?
|
Growth Differentiation Factor 15 | 3 | 2023 | 176 | 0.360 |
Why?
|
Stroke | 12 | 2023 | 9975 | 0.360 |
Why?
|
Diabetic Angiopathies | 3 | 2015 | 819 | 0.360 |
Why?
|
Glucocorticoids | 3 | 2017 | 2107 | 0.350 |
Why?
|
Cardiology | 4 | 2019 | 1668 | 0.340 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2023 | 851 | 0.340 |
Why?
|
Patient Admission | 2 | 2018 | 1380 | 0.340 |
Why?
|
Intermittent Claudication | 3 | 2017 | 309 | 0.340 |
Why?
|
Monitoring, Physiologic | 2 | 2021 | 1738 | 0.340 |
Why?
|
Patient Discharge | 4 | 2023 | 3317 | 0.340 |
Why?
|
Proportional Hazards Models | 14 | 2023 | 12354 | 0.340 |
Why?
|
Comorbidity | 14 | 2023 | 10380 | 0.330 |
Why?
|
Electrocardiography | 10 | 2020 | 6441 | 0.320 |
Why?
|
Microcirculation | 1 | 2013 | 1287 | 0.320 |
Why?
|
Influenza Vaccines | 3 | 2022 | 738 | 0.320 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2023 | 3047 | 0.310 |
Why?
|
Risk Factors | 42 | 2023 | 72252 | 0.310 |
Why?
|
Terminal Care | 2 | 2020 | 1694 | 0.310 |
Why?
|
Societies, Medical | 3 | 2019 | 3740 | 0.300 |
Why?
|
Pregnancy Complications | 3 | 2010 | 2861 | 0.300 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2009 | 740 | 0.300 |
Why?
|
Thrombosis | 2 | 2013 | 2968 | 0.300 |
Why?
|
Fibrinolysis | 1 | 2008 | 322 | 0.290 |
Why?
|
Heart Arrest | 6 | 2019 | 1470 | 0.290 |
Why?
|
Obesity | 8 | 2023 | 12744 | 0.290 |
Why?
|
Dose-Response Relationship, Drug | 13 | 2021 | 10940 | 0.280 |
Why?
|
Pandemics | 6 | 2023 | 8385 | 0.280 |
Why?
|
RNA Interference | 3 | 2024 | 2890 | 0.280 |
Why?
|
Single-Blind Method | 7 | 2019 | 1586 | 0.270 |
Why?
|
Kaplan-Meier Estimate | 13 | 2019 | 6539 | 0.260 |
Why?
|
Pain | 2 | 2017 | 4987 | 0.260 |
Why?
|
Uric Acid | 3 | 2023 | 765 | 0.260 |
Why?
|
Ambulatory Care Facilities | 3 | 2019 | 934 | 0.260 |
Why?
|
Directive Counseling | 1 | 2006 | 166 | 0.250 |
Why?
|
Endpoint Determination | 2 | 2018 | 601 | 0.250 |
Why?
|
Myocardium | 3 | 2013 | 4775 | 0.250 |
Why?
|
Coronary Angiography | 6 | 2018 | 4576 | 0.250 |
Why?
|
Coronary Disease | 3 | 2018 | 6078 | 0.250 |
Why?
|
Influenza, Human | 3 | 2022 | 1480 | 0.240 |
Why?
|
American Heart Association | 2 | 2019 | 1057 | 0.240 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2017 | 1265 | 0.240 |
Why?
|
Morbidity | 8 | 2020 | 1768 | 0.240 |
Why?
|
Algorithms | 6 | 2021 | 13869 | 0.240 |
Why?
|
Time Factors | 20 | 2021 | 40038 | 0.240 |
Why?
|
Sleep Apnea Syndromes | 2 | 2012 | 944 | 0.230 |
Why?
|
Dihydropyridines | 1 | 2023 | 67 | 0.230 |
Why?
|
Disease Progression | 8 | 2020 | 13273 | 0.230 |
Why?
|
Kidney Failure, Chronic | 3 | 2016 | 2534 | 0.230 |
Why?
|
Coronary Artery Disease | 6 | 2018 | 6485 | 0.230 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15067 | 0.230 |
Why?
|
Cardiotonic Agents | 3 | 2018 | 535 | 0.230 |
Why?
|
Health Status | 6 | 2023 | 4031 | 0.230 |
Why?
|
Aortic Diseases | 1 | 2009 | 743 | 0.220 |
Why?
|
Erythrocyte Indices | 1 | 2023 | 146 | 0.220 |
Why?
|
Clinical Trials as Topic | 6 | 2024 | 7908 | 0.220 |
Why?
|
Incidence | 12 | 2021 | 20948 | 0.220 |
Why?
|
Polypharmacy | 2 | 2023 | 294 | 0.210 |
Why?
|
Malnutrition | 2 | 2019 | 625 | 0.210 |
Why?
|
Telemetry | 2 | 2016 | 208 | 0.210 |
Why?
|
Chronic Disease | 9 | 2023 | 9139 | 0.210 |
Why?
|
United States | 29 | 2024 | 69859 | 0.210 |
Why?
|
Protease Inhibitors | 2 | 2016 | 792 | 0.210 |
Why?
|
Research Design | 3 | 2023 | 5983 | 0.210 |
Why?
|
Heart Ventricles | 5 | 2019 | 3817 | 0.210 |
Why?
|
Injections, Subcutaneous | 1 | 2023 | 667 | 0.200 |
Why?
|
Echocardiography | 10 | 2019 | 5096 | 0.200 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1534 | 0.200 |
Why?
|
Aortic Valve | 2 | 2008 | 1920 | 0.200 |
Why?
|
Systole | 7 | 2020 | 958 | 0.190 |
Why?
|
Renal Insufficiency | 2 | 2018 | 805 | 0.190 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2016 | 0.190 |
Why?
|
Receptors, Angiotensin | 1 | 2021 | 141 | 0.190 |
Why?
|
Erythropoietin | 3 | 2015 | 726 | 0.190 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4459 | 0.190 |
Why?
|
Bundle-Branch Block | 2 | 2020 | 269 | 0.180 |
Why?
|
Patient Selection | 3 | 2014 | 4210 | 0.180 |
Why?
|
Sex Factors | 9 | 2021 | 10394 | 0.180 |
Why?
|
Metanephrine | 2 | 2009 | 26 | 0.180 |
Why?
|
North America | 6 | 2020 | 1249 | 0.180 |
Why?
|
Hypoglycemic Agents | 5 | 2020 | 2877 | 0.180 |
Why?
|
Coronary Artery Bypass | 4 | 2021 | 2288 | 0.180 |
Why?
|
Sarcoidosis | 2 | 2019 | 506 | 0.180 |
Why?
|
Creatinine | 6 | 2024 | 1918 | 0.180 |
Why?
|
Aftercare | 2 | 2023 | 870 | 0.170 |
Why?
|
Heart Valve Prosthesis | 1 | 2008 | 1489 | 0.170 |
Why?
|
Europe | 7 | 2020 | 3336 | 0.170 |
Why?
|
Peripheral Arterial Disease | 3 | 2023 | 1188 | 0.170 |
Why?
|
Drug Therapy, Combination | 10 | 2019 | 6487 | 0.170 |
Why?
|
Heart Transplantation | 3 | 2019 | 3113 | 0.170 |
Why?
|
Angiotensin II Type 2 Receptor Blockers | 1 | 2018 | 10 | 0.170 |
Why?
|
Positron-Emission Tomography | 4 | 2019 | 6237 | 0.170 |
Why?
|
Russia | 5 | 2018 | 408 | 0.170 |
Why?
|
Catecholamines | 2 | 2010 | 387 | 0.170 |
Why?
|
Syncope | 3 | 2018 | 429 | 0.170 |
Why?
|
Angina, Unstable | 1 | 2003 | 926 | 0.160 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2020 | 235 | 0.160 |
Why?
|
Diet | 2 | 2023 | 7930 | 0.160 |
Why?
|
Myocardial Ischemia | 2 | 2021 | 2150 | 0.160 |
Why?
|
Retrospective Studies | 18 | 2021 | 77410 | 0.160 |
Why?
|
Stents | 2 | 2009 | 3280 | 0.160 |
Why?
|
Canrenone | 1 | 2017 | 4 | 0.150 |
Why?
|
Funnel Chest | 1 | 2018 | 71 | 0.150 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2023 | 3255 | 0.150 |
Why?
|
Health Status Disparities | 2 | 2019 | 1796 | 0.150 |
Why?
|
Electrophysiology | 1 | 2020 | 1297 | 0.150 |
Why?
|
Postoperative Period | 1 | 2022 | 1841 | 0.150 |
Why?
|
Subclavian Artery | 1 | 2017 | 130 | 0.150 |
Why?
|
Blood Pressure Determination | 2 | 2019 | 633 | 0.150 |
Why?
|
Mortality | 4 | 2021 | 2862 | 0.150 |
Why?
|
Georgia (Republic) | 4 | 2018 | 41 | 0.140 |
Why?
|
Electrodes, Implanted | 1 | 2021 | 825 | 0.140 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1272 | 0.140 |
Why?
|
Pulmonary Edema | 2 | 2009 | 414 | 0.140 |
Why?
|
Dyspnea | 5 | 2023 | 1303 | 0.140 |
Why?
|
Troponin | 3 | 2018 | 524 | 0.140 |
Why?
|
Pacemaker, Artificial | 2 | 2019 | 815 | 0.140 |
Why?
|
Activities of Daily Living | 3 | 2023 | 2419 | 0.140 |
Why?
|
Laboratories | 1 | 2020 | 462 | 0.140 |
Why?
|
Gout | 1 | 2023 | 571 | 0.140 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15526 | 0.140 |
Why?
|
Methylprednisolone | 1 | 2017 | 387 | 0.140 |
Why?
|
Death, Sudden | 1 | 2018 | 302 | 0.140 |
Why?
|
Micronutrients | 1 | 2019 | 375 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 5 | 2017 | 858 | 0.140 |
Why?
|
Hospitals, Community | 1 | 2018 | 347 | 0.140 |
Why?
|
Prostheses and Implants | 2 | 2024 | 1385 | 0.130 |
Why?
|
Thyroid Diseases | 1 | 2019 | 379 | 0.130 |
Why?
|
Respiratory Rate | 1 | 2017 | 162 | 0.130 |
Why?
|
Leg | 2 | 2017 | 1116 | 0.130 |
Why?
|
Anti-Obesity Agents | 1 | 2019 | 217 | 0.130 |
Why?
|
Blood Glucose | 5 | 2022 | 6259 | 0.130 |
Why?
|
Pyridazines | 1 | 2017 | 202 | 0.130 |
Why?
|
Heart Diseases | 1 | 2008 | 2789 | 0.130 |
Why?
|
Myocardial Infarction | 7 | 2021 | 11708 | 0.130 |
Why?
|
Dementia | 2 | 2020 | 2518 | 0.130 |
Why?
|
Age Factors | 9 | 2021 | 18355 | 0.130 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2019 | 844 | 0.130 |
Why?
|
Cardiac Volume | 1 | 2015 | 210 | 0.130 |
Why?
|
Prednisone | 2 | 2017 | 1574 | 0.130 |
Why?
|
Echocardiography, Doppler | 3 | 2014 | 935 | 0.120 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2017 | 162 | 0.120 |
Why?
|
Quality of Health Care | 3 | 2023 | 4370 | 0.120 |
Why?
|
Device Removal | 1 | 2020 | 655 | 0.120 |
Why?
|
Lung | 2 | 2012 | 9858 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 506 | 0.120 |
Why?
|
Insulin | 3 | 2018 | 6584 | 0.120 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3503 | 0.120 |
Why?
|
Emergency Service, Hospital | 2 | 2013 | 7658 | 0.120 |
Why?
|
Sarcopenia | 1 | 2019 | 368 | 0.120 |
Why?
|
Kansas | 2 | 2023 | 39 | 0.120 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12243 | 0.120 |
Why?
|
Pharmacists | 1 | 2016 | 248 | 0.120 |
Why?
|
Decision Support Systems, Clinical | 1 | 2023 | 1164 | 0.120 |
Why?
|
Dietary Proteins | 1 | 2019 | 962 | 0.120 |
Why?
|
Frail Elderly | 1 | 2018 | 693 | 0.110 |
Why?
|
Hospital Mortality | 4 | 2020 | 5316 | 0.110 |
Why?
|
Internationality | 2 | 2019 | 1002 | 0.110 |
Why?
|
Intermittent Positive-Pressure Ventilation | 1 | 2012 | 13 | 0.110 |
Why?
|
Professional Role | 1 | 2016 | 306 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2017 | 949 | 0.110 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2018 | 581 | 0.110 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2013 | 424 | 0.110 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2015 | 493 | 0.110 |
Why?
|
Aldosterone | 2 | 2022 | 877 | 0.110 |
Why?
|
Ultrasonography, Interventional | 2 | 2017 | 1486 | 0.110 |
Why?
|
Pulmonary Medicine | 1 | 2014 | 213 | 0.110 |
Why?
|
Hemofiltration | 1 | 2012 | 57 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2020 | 828 | 0.110 |
Why?
|
Electric Countershock | 1 | 2015 | 534 | 0.100 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 700 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 3 | 2022 | 2267 | 0.100 |
Why?
|
Case-Control Studies | 6 | 2020 | 21733 | 0.100 |
Why?
|
Influenza A virus | 1 | 2015 | 457 | 0.100 |
Why?
|
Cystatin C | 2 | 2023 | 249 | 0.100 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2023 | 148 | 0.100 |
Why?
|
Adult | 23 | 2024 | 213889 | 0.100 |
Why?
|
Sweden | 3 | 2020 | 1341 | 0.100 |
Why?
|
Social Behavior | 1 | 2018 | 1126 | 0.100 |
Why?
|
Coronary Vessels | 2 | 2018 | 3106 | 0.100 |
Why?
|
Counseling | 1 | 2019 | 1523 | 0.100 |
Why?
|
Fetal Death | 2 | 2009 | 448 | 0.100 |
Why?
|
Patient Preference | 1 | 2018 | 889 | 0.100 |
Why?
|
Body Weight | 1 | 2021 | 4670 | 0.090 |
Why?
|
Athletes | 1 | 2018 | 1093 | 0.090 |
Why?
|
Diabetes Complications | 2 | 2020 | 1360 | 0.090 |
Why?
|
Biopsy | 3 | 2017 | 6750 | 0.090 |
Why?
|
Research | 1 | 2019 | 1999 | 0.090 |
Why?
|
Pregnancy Trimester, Third | 2 | 2009 | 571 | 0.090 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2011 | 95 | 0.090 |
Why?
|
Hospitals | 2 | 2021 | 3953 | 0.090 |
Why?
|
New York | 2 | 2023 | 885 | 0.090 |
Why?
|
Prevalence | 6 | 2020 | 15211 | 0.090 |
Why?
|
Income | 1 | 2019 | 1913 | 0.090 |
Why?
|
Statistics as Topic | 2 | 2015 | 2369 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2012 | 1874 | 0.090 |
Why?
|
Logistic Models | 3 | 2020 | 13404 | 0.090 |
Why?
|
Tunica Intima | 1 | 2011 | 463 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2133 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 952 | 0.080 |
Why?
|
Heart Rate | 4 | 2023 | 4091 | 0.080 |
Why?
|
Communication | 1 | 2023 | 3748 | 0.080 |
Why?
|
Case Management | 1 | 2011 | 286 | 0.080 |
Why?
|
Catheter Ablation | 2 | 2015 | 2758 | 0.080 |
Why?
|
Thrombectomy | 1 | 2013 | 680 | 0.080 |
Why?
|
Metformin | 1 | 2016 | 837 | 0.080 |
Why?
|
Data Collection | 1 | 2018 | 3339 | 0.080 |
Why?
|
Vaccination | 2 | 2022 | 3275 | 0.080 |
Why?
|
Outpatients | 3 | 2023 | 1488 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 3912 | 0.080 |
Why?
|
Cohort Studies | 7 | 2020 | 40545 | 0.080 |
Why?
|
Ascorbic Acid | 1 | 2011 | 650 | 0.080 |
Why?
|
Treatment Failure | 4 | 2016 | 2617 | 0.080 |
Why?
|
Patients | 1 | 2014 | 899 | 0.080 |
Why?
|
Pilot Projects | 2 | 2018 | 8316 | 0.080 |
Why?
|
Remission, Spontaneous | 1 | 2008 | 382 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2760 | 0.080 |
Why?
|
Weight Loss | 1 | 2019 | 2625 | 0.080 |
Why?
|
Equipment Design | 1 | 2015 | 3574 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 1 | 2013 | 1133 | 0.070 |
Why?
|
Tachycardia | 1 | 2009 | 619 | 0.070 |
Why?
|
Physical Examination | 3 | 2019 | 1235 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13980 | 0.070 |
Why?
|
Vitamin E | 1 | 2011 | 868 | 0.070 |
Why?
|
Azetidines | 1 | 2008 | 142 | 0.070 |
Why?
|
Body Mass Index | 3 | 2022 | 12718 | 0.070 |
Why?
|
Puerperal Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2614 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2016 | 1783 | 0.070 |
Why?
|
Survival Analysis | 5 | 2021 | 10251 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4221 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4584 | 0.070 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2647 | 0.070 |
Why?
|
Sleep | 1 | 2021 | 4619 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1743 | 0.070 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2008 | 272 | 0.070 |
Why?
|
Urinalysis | 2 | 2018 | 369 | 0.070 |
Why?
|
Boston | 2 | 2016 | 9310 | 0.070 |
Why?
|
Simvastatin | 1 | 2008 | 360 | 0.070 |
Why?
|
Medication Adherence | 1 | 2017 | 2063 | 0.070 |
Why?
|
Anticoagulants | 3 | 2023 | 4599 | 0.070 |
Why?
|
Surgical Instruments | 1 | 2008 | 395 | 0.070 |
Why?
|
South America | 2 | 2016 | 181 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2620 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7784 | 0.060 |
Why?
|
Propanolamines | 1 | 2005 | 167 | 0.060 |
Why?
|
Vasodilator Agents | 2 | 2022 | 974 | 0.060 |
Why?
|
Curriculum | 2 | 2015 | 3603 | 0.060 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.060 |
Why?
|
Sodium-Glucose Transport Proteins | 1 | 2024 | 12 | 0.060 |
Why?
|
Multicenter Studies as Topic | 2 | 2019 | 1676 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2865 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3338 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2008 | 924 | 0.060 |
Why?
|
Blood Urea Nitrogen | 1 | 2024 | 191 | 0.060 |
Why?
|
Argentina | 2 | 2016 | 232 | 0.060 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4931 | 0.060 |
Why?
|
Carbazoles | 1 | 2005 | 226 | 0.060 |
Why?
|
Drug Substitution | 2 | 2016 | 281 | 0.060 |
Why?
|
Atmosphere | 1 | 2023 | 33 | 0.060 |
Why?
|
Pre-Eclampsia | 2 | 2009 | 1200 | 0.060 |
Why?
|
Hypovolemia | 1 | 2023 | 45 | 0.060 |
Why?
|
Postpartum Period | 1 | 2009 | 1086 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2291 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2011 | 1161 | 0.060 |
Why?
|
Calcium | 1 | 2016 | 5755 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1256 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2012 | 1209 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 3537 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 244 | 0.050 |
Why?
|
Headache | 1 | 2009 | 1224 | 0.050 |
Why?
|
Beds | 1 | 2021 | 48 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5611 | 0.050 |
Why?
|
Critical Care | 1 | 2014 | 2647 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3445 | 0.050 |
Why?
|
Fatigue | 2 | 2020 | 1530 | 0.050 |
Why?
|
Canada | 2 | 2017 | 2064 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 471 | 0.050 |
Why?
|
Amyloidosis | 1 | 2008 | 795 | 0.050 |
Why?
|
Probability | 2 | 2021 | 2505 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2024 | 5388 | 0.050 |
Why?
|
Animals | 3 | 2020 | 168660 | 0.050 |
Why?
|
Remote Sensing Technology | 1 | 2021 | 90 | 0.050 |
Why?
|
Glucose | 2 | 2022 | 4398 | 0.050 |
Why?
|
Vaccines, Inactivated | 1 | 2021 | 184 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2023 | 692 | 0.050 |
Why?
|
Ventricular Fibrillation | 1 | 2023 | 538 | 0.050 |
Why?
|
Inpatients | 2 | 2023 | 2515 | 0.040 |
Why?
|
Warfarin | 1 | 2008 | 1497 | 0.040 |
Why?
|
Pregnancy | 3 | 2010 | 29140 | 0.040 |
Why?
|
Registries | 3 | 2020 | 8090 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1859 | 0.040 |
Why?
|
Self Efficacy | 1 | 2023 | 615 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2278 | 0.040 |
Why?
|
Asia, Western | 1 | 2018 | 20 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35409 | 0.040 |
Why?
|
Ultrasonography | 1 | 2012 | 5986 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3778 | 0.040 |
Why?
|
Europe, Eastern | 1 | 2018 | 75 | 0.040 |
Why?
|
Recurrence | 3 | 2018 | 8337 | 0.040 |
Why?
|
Cholesterol, LDL | 2 | 2021 | 2354 | 0.040 |
Why?
|
Asia, Southeastern | 1 | 2018 | 111 | 0.040 |
Why?
|
Quebec | 1 | 2018 | 134 | 0.040 |
Why?
|
Americas | 1 | 2018 | 110 | 0.040 |
Why?
|
Cost of Illness | 2 | 2020 | 1859 | 0.040 |
Why?
|
Mitral Valve Insufficiency | 1 | 2008 | 1421 | 0.040 |
Why?
|
Biological Availability | 1 | 2019 | 397 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.040 |
Why?
|
Medicare | 3 | 2024 | 6565 | 0.040 |
Why?
|
Angioedema | 1 | 2019 | 187 | 0.040 |
Why?
|
Digoxin | 1 | 2018 | 250 | 0.040 |
Why?
|
Nausea | 1 | 2020 | 674 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12954 | 0.040 |
Why?
|
Latin America | 1 | 2018 | 379 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 841 | 0.040 |
Why?
|
Asia | 1 | 2018 | 609 | 0.040 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2017 | 38 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1360 | 0.040 |
Why?
|
Transducers, Pressure | 1 | 2016 | 56 | 0.030 |
Why?
|
Protein Precursors | 1 | 2020 | 1154 | 0.030 |
Why?
|
Recovery of Function | 2 | 2017 | 2922 | 0.030 |
Why?
|
Young Adult | 4 | 2017 | 56392 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1674 | 0.030 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2016 | 126 | 0.030 |
Why?
|
Wireless Technology | 1 | 2016 | 100 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4925 | 0.030 |
Why?
|
Polysomnography | 1 | 2021 | 1776 | 0.030 |
Why?
|
Credentialing | 1 | 2015 | 126 | 0.030 |
Why?
|
Heart Conduction System | 1 | 2020 | 1047 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2023 | 1636 | 0.030 |
Why?
|
Sarcomeres | 1 | 2017 | 374 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2014 | 169 | 0.030 |
Why?
|
RNA | 1 | 2024 | 2748 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5078 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1146 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6311 | 0.030 |
Why?
|
USSR | 1 | 2012 | 21 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5952 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2899 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 953 | 0.030 |
Why?
|
Australia | 1 | 2016 | 1167 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2017 | 599 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1150 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1125 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2922 | 0.030 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2583 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 725 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 21675 | 0.030 |
Why?
|
Brazil | 1 | 2016 | 1264 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19894 | 0.020 |
Why?
|
Drug Interactions | 1 | 2016 | 1460 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2170 | 0.020 |
Why?
|
Placebo Effect | 1 | 2015 | 503 | 0.020 |
Why?
|
Dependovirus | 1 | 2016 | 705 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2267 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 426 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2010 | 266 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1582 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 980 | 0.020 |
Why?
|
Health Care Costs | 1 | 2003 | 3207 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 299 | 0.020 |
Why?
|
Amlodipine | 1 | 2009 | 83 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2011 | 684 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2016 | 861 | 0.020 |
Why?
|
Amiodarone | 1 | 2010 | 211 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1813 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9848 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6457 | 0.020 |
Why?
|
Bumetanide | 1 | 2008 | 95 | 0.020 |
Why?
|
New England | 1 | 2011 | 1022 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3530 | 0.020 |
Why?
|
Radial Artery | 1 | 2009 | 193 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3608 | 0.020 |
Why?
|
Depression | 2 | 2020 | 7760 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8637 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2018 | 1537 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2453 | 0.020 |
Why?
|
Manometry | 1 | 2009 | 445 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1620 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3794 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7150 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9677 | 0.020 |
Why?
|
Thromboembolism | 1 | 2013 | 987 | 0.020 |
Why?
|
Developing Countries | 1 | 2019 | 2815 | 0.020 |
Why?
|
Demography | 1 | 2011 | 1653 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4467 | 0.020 |
Why?
|
Shock, Septic | 1 | 2013 | 775 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2241 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2016 | 3421 | 0.020 |
Why?
|
Biological Transport | 1 | 2010 | 2119 | 0.020 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2010 | 788 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5100 | 0.020 |
Why?
|
Heart | 1 | 2018 | 4460 | 0.020 |
Why?
|
Survivors | 1 | 2014 | 2291 | 0.010 |
Why?
|
Creatine Kinase, MB Form | 1 | 2004 | 214 | 0.010 |
Why?
|
Inflammation | 1 | 2024 | 10629 | 0.010 |
Why?
|
Smoking | 1 | 2021 | 8984 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14714 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2883 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 85729 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2011 | 2453 | 0.010 |
Why?
|
Life Expectancy | 1 | 2009 | 1184 | 0.010 |
Why?
|
Kinetics | 1 | 2010 | 6476 | 0.010 |
Why?
|
Lower Extremity | 1 | 2010 | 1158 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2008 | 970 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2004 | 694 | 0.010 |
Why?
|
Myocarditis | 1 | 2010 | 768 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12944 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3070 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3833 | 0.010 |
Why?
|
Isoenzymes | 1 | 2004 | 1728 | 0.010 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25032 | 0.010 |
Why?
|
Sulfonamides | 1 | 2008 | 1938 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4152 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 7010 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3391 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2010 | 3863 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29777 | 0.010 |
Why?
|
Child | 1 | 2017 | 77637 | 0.010 |
Why?
|